Found 0 matching trials
Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy PHASE4 Our first hypothesis is that dose adjustment of aspirin and clopidogrel bas...
Show More Location
Institut de Cardiologie- Hopital la Pitié Salpétrière
Learn More & Join Trial
Platelet Inhibition in the Acute Phase of STEMI N/A Background:
Dual antithrombotic treatment with aspirin and clopidogrel is ...
Show More Location
Aarhus University Hospital, Skejby
Learn More & Join Trial
CRETA (Clopidogrel Responsiveness in Essential ThrombocithemiA) N/A Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm ass...
Show More Location
Azienda USL di Pescara - Ospedale Santo Spirito
Learn More & Join Trial
REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction PHASE4 The purpose of this study is to compare 3 point-of-care methods for monitor...
Show More Location
University Hospital Ostrava
Learn More & Join Trial
Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm PHASE4 Perform a randomized comparison study of dual-antiplatelet (aspirin, prasug...
Show More Location
Seoul National Univeristy Bundang Hospital
Learn More & Join Trial
Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients PHASE4 The purpose of this study is to assess the pharmacodynamic effect of ticagr...
Show More Learn More & Join Trial
Platelet Reactivity After an Eastern Asian Loading Dose of Prasugrel in Taiwanese ACS Patients NA Prasugrel has a faster onset of action and greater platelet inhibition with...
Show More Location
Feng Yuan Hospital
Learn More & Join Trial
Genotype and Platelet Reactivity in Patients on Hemodialysis PHASE3 Patients with end stage renal disease (ESRD) on hemodialysis (HD) exhibited...
Show More Location
Kyung Hee University Hospital
Learn More & Join Trial
"Potential Effect of Acute and Chronic Caffeine Administration on Platelet Reactivity in Patient With Coronary Artery Disease on Dual Antiplatelet Therapy" NA Prasugrel is a potent thienopyridine antiplatelet agent that selectively an...
Show More Location
Sapienza University of Rome
Learn More & Join Trial
Platelet Function in Resuscitated Patients-2 N/A Approx. 65% of resuscitated patients at the intensive care unit for interna...
Show More Location
Medical University of Graz
Learn More & Join Trial